Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03083184 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

Study acronym: ETERNITY
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Jan 2021 to Dec 2026
    • Start date changed from estimate of Apr 2017 to Feb 9, 2018
    • Study completion date: Mar 2021 to Dec 2027
    • Site details revised
  2. Study title shortened, about 9 words
    • Eligibility criteria shortened, about 5 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assessed the efficacy of a combined solution of ethanol (4%) and low molecular weight heparins LMWH in preventing tunnelled dialysis catheter infection in chronic hemodialysis patients
Trial Details
NCT Number NCT03083184
Lead Sponsor University Hospital, Clermont-Ferrand
Collaborators: Ministry of Health, France, CH du Puy en Velay, Hôpital Emile Roux, University Hospital, Toulouse, Centre hospitalier de Chambéry, Calydial, Hôpital Edouard Herriot, Nouvel Hôpital Civil, 1 place de l'Hôpital 67091 Strasbourg cedex, Hôpital Lapeyronie, Centre de dialyse d'Alès, University Hospital of Saint-Etienne, Perpignan Hospital Center, POLYCLINIQUE SAINT-ROCH, CHU Hôpital Maison Blanche, 45 Rue Cognacq-Jay 51092 REIMS Cedex
Conditions
(from sponsor)		 Tunnelled Hemodialysis Catheter Infection
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov